| Oct 29 |
EyePoint Pharmaceuticals (EYPT) Soars 27.6%: Is Further Upside Left in the Stock?
|
| Oct 29 |
QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment
|
| Oct 18 |
Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
|
| Oct 16 |
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
| Oct 11 |
QIAGEN's TB Testing Business Gets New Exposure at Global Summit
|
| Oct 11 |
OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies
|
| Oct 10 |
QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications
|
| Oct 10 |
QIAGEN N.V. to release results for Q3 2024 and hold webcast
|
| Oct 7 |
Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer
|
| Oct 7 |
Reasons to Retain QIAGEN Stock in Your Portfolio for Now
|
